Five Prime Therapeutics Appoints Bryan Irving, Ph.D., as Chief Scientific Officer
FIVE PRIME THERAPEUTICS (FPRX)
Last five prime therapeutics earnings: 2/27 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.fiveprime.com/investor-relations
Company Research
Source: Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced the appointment of Bryan Irving, Ph.D., as Executive Vice President and Chief Scientific Officer. “We are delighted to promote Bryan to this important leadership role. Bryan will set forth the discovery strategy and priorities for the optimal use of our comprehensive IND engine to expand our product pipeline,” said Aron Knickerbocker, chief executive officer of Five Prime Therapeutics. “In addition to his leadership and managerial abilities, Bryan brings a passion for innovative science and extensive immuno-oncology experience. Among his most notable contributions is his inventorship and leadership in developing atezolizumab (Tecentriq®), which is now approved for the treatment of several cancers. We
Show less
Read more
Impact Snapshot
Event Time:
FPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FPRX alerts
High impacting FIVE PRIME THERAPEUTICS news events
Weekly update
A roundup of the hottest topics